Business
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and
About this update from Caredx, Inc.
[{"type":"text","content":" BRISBANE, Calif.--(BUSINESS WIRE)--\nCareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.\n\n\nCareDx’s management is scheduled to present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 12:30 PM PT / 3:30 PM ET. To listen to the webcast, please visit the Events & Presentations section of CareDx’s investor relations website at: investors.caredxinc.com.\n\n\nAbout CareDx – The Transplant Company™\n\n\nCareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230831948683/en/\n\nCareDx, Inc.\n\n\nMedia Relations\nAnna Czene\n818-731-2203\[email protected]\n\n\nInvestor Relations\nGreg Chodaczek\[email protected]\n\n\nSource: CareDx, Inc.","length":3397,"tagName":"div"}]